JSL
ATRS

JT Stratford LLC’s Antares Pharma, Inc. ATRS Stock Holding History

JT Stratford LLC’s Portfolio ATRS Stock Details ATRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-14,053
Closed -$58K – 240
2022
Q1 		$58K Sell
14,053
-3,320
-19% -$12K 0.02% 201
2021
Q4 		$62K Buy
+17,373
New +$60.8K 0.02% 209

Other funds holding ATRS

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

JT Stratford LLC's ATRS Position: Q2 2022 in Review

JT Stratford LLC sold out of Antares Pharma, Inc. (ATRS) in Q2 2022, closing a stake of 14,053 shares — an estimated $58K sold.

JT Stratford LLC first reported a position in ATRS in Q4 2021 and held it in 2 quarters. The position peaked at $62K in Q4 2021. 1 fund tracked by Wall St. Rank holds ATRS as of Q2 2022.

  • JT Stratford LLC reported no remaining Antares Pharma, Inc. position as of Q2 2022 after selling out during the quarter.
  • JT Stratford LLC sold 14,053 Antares Pharma, Inc. shares in Q2 2022, an estimated $58K.
  • JT Stratford LLC first reported a position in Antares Pharma, Inc. in Q4 2021 and held it in 2 quarters.
  • JT Stratford LLC's Antares Pharma, Inc. position peaked at $62K in Q4 2021.
  • 1 fund tracked by Wall St. Rank held Antares Pharma, Inc. as of Q2 2022.

Based on JT Stratford LLC's 13F filing for Q2 2022, filed 15 Aug 2022.